サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1380310

マルチプレックスアッセイ市場：製品・サービス、タイプ、技術、用途、エンドユーザー別-2023-2030年世界予測

Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, Protein Multiplex Assays), Technology, Application, End User - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マルチプレックスアッセイ市場：製品・サービス、タイプ、技術、用途、エンドユーザー別-2023-2030年世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マルチプレックスアッセイ市場は、2022年の35億9,000万米ドルから2030年には68億8,000万米ドルに達すると予測され、予測期間中のCAGRは8.46%です。

マルチプレックスアッセイの世界市場

主な市場の統計
市場金額：基準年[2022] 35億9,000万米ドル
推定市場金額[2023] 38億9,000万米ドル
予測市場金額[2030] 68億8,000万米ドル
CAGR（%） 8.46%
マルチプレックスアッセイ Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはマルチプレックスアッセイ市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.マルチプレックスアッセイ市場の市場規模および予測は？

2.マルチプレックスアッセイ市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.マルチプレックスアッセイ市場における競争戦略の窓とは？

4.マルチプレックスアッセイ市場の最新技術動向と規制の枠組みは？

5.マルチプレックスアッセイ市場における主要ベンダーの市場シェアは？

6.マルチプレックスアッセイ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患や感染症の増加と早期診断への急速な移行
      • 個別化された精密医薬品の使用量の急増
      • 医薬品開発における複数のアッセイの応用の拡大
    • 抑制要因
      • マルチプレックスアッセイに関連するせん断の複雑さと機器の高コスト
    • 機会
      • 臨床診断における多重化の新技術
      • 臨床現場での自動化された器具や機器の導入の可能性
    • 課題
      • 熟練した経験豊富なヘルスケア従事者の不足
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 マルチプレックスアッセイ市場製品&サービス別

  • 消耗品
  • 機器
  • ソフトウェアとサービス

第7章 マルチプレックスアッセイ市場：タイプ別

  • セルベースのマルチプレックスアッセイ
  • 核酸マルチプレックスアッセイ
    • ビーズベースの核酸アッセイ
    • 平面核酸アッセイ
  • タンパク質マルチプレックスアッセイ
    • ビーズベースのタンパク質アッセイ
    • 平面タンパク質アッセイ

第8章 マルチプレックスアッセイ市場：技術別

  • フローサイトメトリー
  • 蛍光検出
  • 発光
  • マルチプレックスリアルタイムフローサイトメトリー
  • マルチプレックスリアルタイムPCR

第9章 マルチプレックスアッセイ市場：用途別

  • 臨床診断
    • 自己免疫疾患
    • がん
    • 心血管疾患
    • 感染症
    • 代謝および内分泌疾患
    • 神経系疾患
  • 研究開発
    • バイオマーカーの発見と検証
    • 創薬と開発

第10章 マルチプレックスアッセイ市場：エンドユーザー別

  • 病院および調査機関
  • 製薬およびバイオテクノロジー企業
  • リファレンスラボ

第11章 南北アメリカのマルチプレックスアッセイ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のマルチプレックスアッセイ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのマルチプレックスアッセイ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Abcam PLC
    • Agilent Technologies, Inc.
    • Antigenix America, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • Cayman Chemical Company
    • Charles River Laboratories
    • Enfer Group
    • Enzo Life Sciences, Inc.
    • Eve Technologies Corp.
    • Flagship Biosciences Inc.
    • Future Diagnostics Solutions B.V.
    • Gnome Diagnostics and Gnome Sciences
    • Illumina, Inc.
    • Merck KGaA
    • MESO SCALE DIAGNOSTICS, LLC
    • Novatein Biosciences Inc.
    • PerkinElmer, Inc.
    • Protavio Ltd.
    • Siemens Healthineers AG
    • Solis BioDyne OU
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX ASSAYS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. MULTIPLEX ASSAYS MARKET DYNAMICS
  • FIGURE 7. MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
  • FIGURE 8. MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 10. MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 12. MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 16. MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 13. MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR NUCLEIC ACID ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 17. MULTIPLEX ASSAYS MARKET SIZE, BY BEAD-BASED PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MULTIPLEX ASSAYS MARKET SIZE, BY PLANAR PROTEIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MULTIPLEX ASSAYS MARKET SIZE, BY MULTIPLEX REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 28. MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. MULTIPLEX ASSAYS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. MULTIPLEX ASSAYS MARKET SIZE, BY METABOLISM & ENDOCRINOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. MULTIPLEX ASSAYS MARKET SIZE, BY NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. MULTIPLEX ASSAYS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN MULTIPLEX ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 344. SAUDI ARABIA MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID MULTIPLEX ASSAYS, 2018-2030 (US
目次
Product Code: MRR-8201ABF20BDA

The Multiplex Assays Market is projected to reach USD 6.88 billion by 2030 from USD 3.59 billion in 2022, at a CAGR of 8.46% during the forecast period.

Global Multiplex Assays Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 3.59 billion
Estimated Year Value [2023] USD 3.89 billion
Forecast Year Value [2030] USD 6.88 billion
CAGR (%) 8.46%
Multiplex Assays Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Multiplex Assays Market.

Based on Product & Service, market is studied across Consumables, Instruments, and Software & Services. The Consumables is projected to witness significant market share during forecast period.

Based on Type, market is studied across Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, and Protein Multiplex Assays. The Nucleic Acid Multiplex Assays is further studied across Bead-Based Nucleic Acid Assays and Planar Nucleic Acid Assays. The Protein Multiplex Assays is further studied across Bead-Based Protein Assays and Planar Protein Assays. The Nucleic Acid Multiplex Assays is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time Flow Cytometry, and Multiplex Real-Time PCR. The Multiplex Real-Time Flow Cytometry is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Diagnostics and Research & Development. The Clinical Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Infectious Diseases, Metabolism & Endocrinology Disorders, and Nervous System Disorders. The Research & Development is further studied across Biomarker Discovery & Validation and Drug Discovery & Development. The Clinical Diagnostics is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals & Research Institutes, Pharmaceutical & Biotechnology Companies, and Reference Laboratories. The Hospitals & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Multiplex Assays Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Multiplex Assays Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Multiplex Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Antigenix America, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cayman Chemical Company, Charles River Laboratories, Enfer Group, Enzo Life Sciences, Inc., Eve Technologies Corp., Flagship Biosciences Inc., Future Diagnostics Solutions B.V., Gnome Diagnostics and Gnome Sciences, Illumina, Inc., Merck KGaA, MESO SCALE DIAGNOSTICS, LLC, Novatein Biosciences Inc., PerkinElmer, Inc., Protavio Ltd., Siemens Healthineers AG, Solis BioDyne OU, and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Multiplex Assays Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Multiplex Assays Market?

3. What is the competitive strategic window for identifying opportunities in the Multiplex Assays Market?

4. What are the latest technology trends and regulatory frameworks in the Multiplex Assays Market?

5. What is the market share of the leading vendors in the Multiplex Assays Market?

6. Which modes and strategic moves are suitable for entering the Multiplex Assays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Multiplex Assays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising chronic and infectious disease and rapid shift towards early diagnosis
      • 5.1.1.2. Surge in usage of personalized-precision medications
      • 5.1.1.3. Growing application of multiple assays in drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Associated shear complexity of multiplex assays and high cost of instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technology of multiplexing in clinical diagnostics
      • 5.1.3.2. Potential adoption of automated instruments and equipment in clinical practice
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled and experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Multiplex Assays Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software & Services

7. Multiplex Assays Market, by Type

  • 7.1. Introduction
  • 7.2. Cell-Based Multiplex Assays
  • 7.3. Nucleic Acid Multiplex Assays
    • 7.4.1. Bead-Based Nucleic Acid Assays
    • 7.4.2. Planar Nucleic Acid Assays
  • 7.4. Protein Multiplex Assays
    • 7.5.1. Bead-Based Protein Assays
    • 7.5.2. Planar Protein Assays

8. Multiplex Assays Market, by Technology

  • 8.1. Introduction
  • 8.2. Flow Cytometry
  • 8.3. Fluorescence Detection
  • 8.4. Luminescence
  • 8.5. Multiplex Real-Time Flow Cytometry
  • 8.6. Multiplex Real-Time PCR

9. Multiplex Assays Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
    • 9.3.1. Autoimmune Diseases
    • 9.3.2. Cancer
    • 9.3.3. Cardiovascular Diseases
    • 9.3.4. Infectious Diseases
    • 9.3.5. Metabolism & Endocrinology Disorders
    • 9.3.6. Nervous System Disorders
  • 9.3. Research & Development
    • 9.4.1. Biomarker Discovery & Validation
    • 9.4.2. Drug Discovery & Development

10. Multiplex Assays Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals & Research Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies
  • 10.4. Reference Laboratories

11. Americas Multiplex Assays Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Multiplex Assays Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Multiplex Assays Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Abbott Laboratories
    • 15.1.2. Abcam PLC
    • 15.1.3. Agilent Technologies, Inc.
    • 15.1.4. Antigenix America, Inc.
    • 15.1.5. Becton, Dickinson and Company
    • 15.1.6. Bio-Rad Laboratories, Inc.
    • 15.1.7. Bio-Techne Corporation
    • 15.1.8. Cayman Chemical Company
    • 15.1.9. Charles River Laboratories
    • 15.1.10. Enfer Group
    • 15.1.11. Enzo Life Sciences, Inc.
    • 15.1.12. Eve Technologies Corp.
    • 15.1.13. Flagship Biosciences Inc.
    • 15.1.14. Future Diagnostics Solutions B.V.
    • 15.1.15. Gnome Diagnostics and Gnome Sciences
    • 15.1.16. Illumina, Inc.
    • 15.1.17. Merck KGaA
    • 15.1.18. MESO SCALE DIAGNOSTICS, LLC
    • 15.1.19. Novatein Biosciences Inc.
    • 15.1.20. PerkinElmer, Inc.
    • 15.1.21. Protavio Ltd.
    • 15.1.22. Siemens Healthineers AG
    • 15.1.23. Solis BioDyne OU
    • 15.1.24. Thermo Fisher Scientific Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing